Daniel D. Waller

763 total citations
14 papers, 280 citations indexed

About

Daniel D. Waller is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Daniel D. Waller has authored 14 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Daniel D. Waller's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Daniel D. Waller is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Daniel D. Waller collaborates with scholars based in Canada, United States and Singapore. Daniel D. Waller's co-authors include Youla S. Tsantrizos, Jaeok Park, Michaël Sébag, David Y. Thomas, Malcolm Whiteway, C. Patrick Lusk, Jianbiao Zhou, Cunle Wu, Jing-Yuan Chooi and Phyllis S.Y. Chong and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Daniel D. Waller

13 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel D. Waller Canada 8 209 63 53 41 39 14 280
Kwang-Sung Ahn South Korea 11 195 0.9× 76 1.2× 35 0.7× 32 0.8× 100 2.6× 18 317
Juan Esquivel United States 6 285 1.4× 71 1.1× 43 0.8× 61 1.5× 15 0.4× 7 457
Iryna Kolosenko Sweden 11 237 1.1× 116 1.8× 50 0.9× 91 2.2× 43 1.1× 19 383
Savita Lochab India 11 242 1.2× 58 0.9× 19 0.4× 48 1.2× 42 1.1× 26 362
Stela Álvarez-Fernández Spain 8 216 1.0× 83 1.3× 34 0.6× 76 1.9× 118 3.0× 11 363
Shiho Fujiwara Japan 8 195 0.9× 130 2.1× 21 0.4× 51 1.2× 125 3.2× 16 323
Viacheslav V. Senichkin Sweden 8 241 1.2× 93 1.5× 21 0.4× 48 1.2× 24 0.6× 13 302
Tristan M. G. Kenney Canada 4 244 1.2× 49 0.8× 18 0.3× 44 1.1× 13 0.3× 6 297
Jinhong Cho South Korea 6 293 1.4× 106 1.7× 39 0.7× 52 1.3× 16 0.4× 8 357

Countries citing papers authored by Daniel D. Waller

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Waller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Waller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Waller more than expected).

Fields of papers citing papers by Daniel D. Waller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Waller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Waller. The network helps show where Daniel D. Waller may publish in the future.

Co-authorship network of co-authors of Daniel D. Waller

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Waller. A scholar is included among the top collaborators of Daniel D. Waller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Waller. Daniel D. Waller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Meermeier, Erin W., Silvia Selleri, Mehdi Arbabi Ghahroudi, et al.. (2023). Lymphodepletion Enables Successful BCMA CAR-T Cell Engraftment and Tumour Control in the Syngeneic Vk*MYC Model of Aggressive Myeloma. Blood. 142(Supplement 1). 3445–3445. 1 indexed citations
2.
3.
Matralis, Alexios N., et al.. (2022). Synthesis and Evaluation of Structurally Diverse C-2-Substituted Thienopyrimidine-Based Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase. Journal of Medicinal Chemistry. 65(3). 2471–2496. 6 indexed citations
4.
Croucher, Danielle, Laura M. Richards, Daniel D. Waller, et al.. (2021). Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. Nature Communications. 12(1). 6322–6322. 20 indexed citations
5.
Waller, Daniel D., Yury Monczak, René P. Michel, Chaim Shustik, & Michaël Sébag. (2020). Spontaneous remission and clonal evolution in lenalidomide associated secondary AML. Leukemia & lymphoma. 61(7). 1724–1727.
6.
Chong, Phyllis S.Y., Jianbiao Zhou, Jing-Yuan Chooi, et al.. (2019). IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma. Cancer Research. 79(18). 4679–4688. 59 indexed citations
7.
Cencic, Regina, Jennifer Chu, Daniel D. Waller, et al.. (2019). Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation. Scientific Reports. 9(1). 1265–1265. 10 indexed citations
8.
Waller, Daniel D., Jaeok Park, & Youla S. Tsantrizos. (2019). Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers. Critical Reviews in Biochemistry and Molecular Biology. 54(1). 41–60. 65 indexed citations
9.
Croucher, Danielle, Marta Chesi, Zhihua Li, et al.. (2018). A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma. Blood. 132(Supplement 1). 56–56. 3 indexed citations
10.
Waller, Daniel D., et al.. (2018). Unraveling the Prenylation–Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors. Journal of Medicinal Chemistry. 61(15). 6904–6917. 38 indexed citations
11.
Waller, Daniel D., Gregor Jansen, Makan Golizeh, et al.. (2016). A Covalent Cysteine‐Targeting Kinase Inhibitor of Ire1 Permits Allosteric Control of Endoribonuclease Activity. ChemBioChem. 17(9). 843–851. 12 indexed citations
12.
Gately, Kathy, Duncan J. Stewart, Daniel D. Waller, Alun M. Davies, & Kenneth J. O’Byrne. (2008). Phosphorylation and nuclear localisation of Akt is induced by hypoxia and associated with a poor prognosis in malignant pleural mesothelioma. Journal of Clinical Oncology. 26(15_suppl). 22034–22034. 2 indexed citations
13.
14.
Lusk, C. Patrick, Daniel D. Waller, Taras Makhnevych, et al.. (2007). Nup53p is a Target of Two Mitotic Kinases, Cdk1p and Hrr25p. Traffic. 8(6). 647–660. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwang-Sung Ahn Breakdown of academic impact, for papers by Juan Esquivel Breakdown of academic impact, for papers by Iryna Kolosenko Breakdown of academic impact, for papers by Savita Lochab Breakdown of academic impact, for papers by Stela Álvarez-Fernández Breakdown of academic impact, for papers by Shiho Fujiwara Breakdown of academic impact, for papers by Viacheslav V. Senichkin Breakdown of academic impact, for papers by Tristan M. G. Kenney Breakdown of academic impact, for papers by Jinhong Cho
Rankless by CCL
2026